Table of Content




1. Introduction
1.1. Definition of Nuclear Medicine
1.2. Scope of the Report
1.3. Research Methodology


2. Executive Summary
2.1. Key Findings
2.2. Market Snapshot
2.3. Key Trends


3. Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Diseases
3.1.2. Advancements in Nuclear Imaging and Therapeutics
3.1.3. Growing Demand for Non-invasive Diagnostics
3.1.4. Other Market Drivers
3.2. Market Restraints
3.2.1. High Cost of Nuclear Medicine Procedures
3.2.2. Limited Availability of Radioisotopes
3.2.3. Regulatory and Safety Challenges
3.2.4. Other Market Restraints
3.3. Market Opportunities
3.3.1. Rising Adoption in Emerging European Markets
3.3.2. Innovations in Radiopharmaceuticals
3.3.3. Increasing Focus on Targeted Therapeutics
3.3.4. Other Market Opportunities


4. Europe Nuclear Medicine Market Analysis
4.1. Market Size and Forecast (2024-2034)
4.2. Market Share Analysis by:
4.2.1. Product
4.2.1.1. Diagnostics
4.2.1.1.1. SPECT
4.2.1.1.2. PET
4.2.1.2. Therapeutics
4.2.1.2.1. Alpha Emitters
4.2.1.2.2. Beta Emitters
4.2.2. Application
4.2.2.1. Neurology
4.2.2.2. Cardiology
4.2.2.3. Oncology
4.2.2.4. Others
4.2.3. End User
4.2.3.1. Hospitals & Clinics
4.2.3.2. Diagnostic Centers
4.2.3.3. Others
4.3. Value Chain Analysis
4.4. SWOT Analysis
4.5. Porter’s Five Forces Analysis


5. Regional Market Analysis
5.1. Germany
5.1.1. Market Overview
5.1.2. Market Size and Forecast
5.1.3. Key Trends
5.1.4. Competitive Landscape
5.2. United Kingdom
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.2.3. Key Trends
5.2.4. Competitive Landscape
5.3. France
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.3.3. Key Trends
5.3.4. Competitive Landscape
5.4. Italy
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.4.3. Key Trends
5.4.4. Competitive Landscape
5.5. Spain
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.5.3. Key Trends
5.5.4. Competitive Landscape
5.6. Rest of Europe
5.6.1. Market Overview
5.6.2. Market Size and Forecast
5.6.3. Key Trends
5.6.4. Competitive Landscape


6. Competitive Landscape
6.1. Market Share Analysis of Key Players
6.2. Company Profiles of Key Players
6.2.1. Siemens Healthineers
6.2.2. General Electric Healthcare
6.2.3. Philips Healthcare
6.2.4. Eckert & Ziegler Group
6.2.5. Lantheus Medical Imaging
6.2.6. Jubilant Pharma
6.2.7. Cardinal Health, Inc.
6.2.8. Curium Pharma
6.2.9. Nordion Inc.
6.2.10. Advanced Accelerator Applications S.A.
6.3. Recent Developments and Innovations
6.4. Strategic Initiatives


7. Future Outlook and Market Forecast
7.1. Market Growth Prospects
7.2. Technological Trends and Innovations
7.3. Investment Opportunities
7.4. Strategic Recommendations


8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the Europe Nuclear Medicine Market



List of Figures

List of Figures:

Figure 1: Europe Nuclear Medicine Market: Market Segmentation
Figure 2: Europe Nuclear Medicine Market: Research Methodology
Figure 3: Top Down Approach
Figure 4: Bottom Up Approach
Figure 5: Data Triangulation and Validation
Figure 6: Europe Nuclear Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 7: Europe Nuclear Medicine Market: Porter’s Five Forces Model Analysis
Figure 8: Europe Nuclear Medicine Market: Value Chain Analysis
Figure 9: Europe Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 10: Europe Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 11: Europe Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 12: Germany Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 13: Germany Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 14: Germany Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 15: U.K. Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 16: U.K. Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 17: U.K. Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 18: France Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 19: France Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 20: France Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 21: Italy Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 22: Italy Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 23: Italy Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 24: Spain Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 25: Spain Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 26: Spain Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 27: Rest of Europe Nuclear Medicine Market Share Analysis, By Product Type, 2024-2034
Figure 28: Rest of Europe Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 29: Rest of Europe Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 30: Europe Nuclear Medicine Market: Competitive Benchmarking
Figure 31: Europe Nuclear Medicine Market: Vendor Share Analysis, 2024
Figure 32: Europe Nuclear Medicine Market: Regulatory Landscape
Figure 33: Europe Nuclear Medicine Market: Technological Innovations
Figure 34: Europe Nuclear Medicine Market: Future Outlook
Figure 35: Europe Nuclear Medicine Market: Forecast Methodology
Figure 36: Europe Nuclear Medicine Market: Regional Demand Distribution
Figure 37: Europe Nuclear Medicine Market: Price Trends and Forecast
Figure 38: Europe Nuclear Medicine Market: Supply Chain Analysis
Figure 39: Europe Nuclear Medicine Market: Consumer Preferences and Trends
Figure 40: Europe Nuclear Medicine Market: Market Entry Strategies

List of Tables

List of Tables:

Table 1: Europe Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 2: Europe Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 3: Europe Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 4: Europe Nuclear Medicine Market, By Country, 2024-2034 (USD Million)
Table 5: Germany Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 6: Germany Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 7: Germany Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 8: U.K. Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 9: U.K. Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 10: U.K. Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 11: France Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 12: France Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 13: France Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 14: Italy Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 15: Italy Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 16: Italy Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 17: Spain Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 18: Spain Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 19: Spain Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 20: Rest of Europe Nuclear Medicine Market, By Product, 2024-2034 (USD Million)
Table 21: Rest of Europe Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 22: Rest of Europe Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 23: Europe Nuclear Medicine Market Revenue by Product, 2024-2034 (USD Million)
Table 24: Europe Nuclear Medicine Market Volume by Product, 2024-2034 (Units)
Table 25: Europe Nuclear Medicine Market Revenue by Application, 2024-2034 (USD Million)
Table 26: Europe Nuclear Medicine Market Volume by Application, 2024-2034 (Units)
Table 27: Europe Nuclear Medicine Market Revenue by End User, 2024-2034 (USD Million)
Table 28: Europe Nuclear Medicine Market Volume by End User, 2024-2034 (Units)
Table 29: Europe Nuclear Medicine Market Revenue by Country, 2024-2034 (USD Million)
Table 30: Europe Nuclear Medicine Market Volume by Country, 2024-2034 (Units)
Table 31: Siemens Healthineers: Company Snapshot
Table 32: Siemens Healthineers: Operating Segments
Table 33: Siemens Healthineers: Product Portfolio
Table 34: General Electric Healthcare: Company Snapshot
Table 35: General Electric Healthcare: Operating Segments
Table 36: General Electric Healthcare: Product Portfolio
Table 37: Philips Healthcare: Company Snapshot
Table 38: Philips Healthcare: Operating Segments
Table 39: Philips Healthcare: Product Portfolio